Figure 2.

Sanger sequencing identification of TNFAIP3 somatic mutations or deletions in pSS patients with lymphoma. Sanger sequencing results for each TNFAIP3-mutated somatic sample are shown. Arrows indicate site of nucleotide change. Traces shown are representative of at least 2 independent amplification and sequencing reactions.